UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Aug 12, 2026
Sale
Calculated transaction value
$62.11K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Aug 11, 2026
Public filing date
Aug 12, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$515.5
Aug 11, 2026
Close before public filing
$515.5
Aug 11, 2026
Return since public filing
-3.57%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 120 shares @ $517.57
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000118
Filing cohort
Transactions in this filing
Showing 15 of 18
Trades
18
Issuers
1
Estimated value
$6.25M
Buys / sales
0 / 16
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Aug 11, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Aug 11, 2026 | $243.85K |
| United Therapeutics Corp UTHR | Sale | Aug 11, 2026 | $624.63K |
| United Therapeutics Corp UTHR | Sale | Aug 11, 2026 | $185.59K |
| United Therapeutics Corp UTHR | Sale | Aug 11, 2026 | $268.79K |
| United Therapeutics Corp UTHR Current | Sale | Aug 11, 2026 | $62.11K |
| United Therapeutics Corp UTHR | Sale | Aug 11, 2026 | $62.27K |
| United Therapeutics Corp UTHR | Sale | Aug 11, 2026 | $104.12K |
| United Therapeutics Corp UTHR | Sale | Aug 11, 2026 | $104.35K |
| United Therapeutics Corp UTHR | Sale | Aug 11, 2026 | $115.59K |
| United Therapeutics Corp UTHR | Sale | Aug 11, 2026 | $198.65K |
| United Therapeutics Corp UTHR | Sale | Aug 11, 2026 | $457.44K |
| United Therapeutics Corp UTHR | Sale | Aug 11, 2026 | $1.43M |
| United Therapeutics Corp UTHR | Sale | Aug 11, 2026 | $492.9K |
| United Therapeutics Corp UTHR | Sale | Aug 11, 2026 | $389.19K |